Astec Lifesciences Ltd.

•

godrejastec.comBSE: 533138NSE: ASTEC

Market Cap₹ 1,700 Cr.

Current Price

High / Low₹ 942 / 513

Stock P/E0.0

Book Value₹ 167

Price to Book3.08

Dividend Yield0.00 %

ROCE-5.7 %

ROE-26.0 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Promoters have been increasing their shareholding - up 5.2pp over 2 years
Working capital cycle has improved - days down from -29 to -47

CONS

Company is loss-making at the operating / net level
Operating cash flow has been negative in recent years
Company has a low return on equity of -27.6% over last 3 years
Receivables are growing faster than sales - a possible quality concern
Company has a low return on capital employed of -7.6%
Interest coverage is weak at -1.3x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsPesticides & Agrochemicals

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	UPL	577.00	24.11	48708.57	1.04	-73.00	58.52	10181.00	10.47	12.00	13.43
2.	PIIND	2396.05	31.20	36352.42	0.63	244.20	-38.95	1702.30	-10.43	16.00	21.69
3.	SUMICHEM	481.50	41.48	24033.87	0.27	214.51	20.45	1063.35	0.62	23.39	21.94
4.	BAYERCROP	3948.35	320.25	17744.71	3.80	321.60	15.39	1835.00	-4.16	30.08	20.03
5.	SHARDACROP	783.10	11.28	7065.17	1.92	88.02	-38.36	1073.77	9.03	31.10	17.32
6.	DHANUKA	977.80	14.68	4358.87	0.20	75.50	27.94	442.02	20.01	24.44	24.83
7.	RALLIS	203.90	24.15	3965.22	1.47	-14.15	-274.26	507.54	7.70	13.23	-0.56
8.	NACLIND	164.35	311.22	3849.79	0.00	20.84	59.82	383.33	-14.50	6.20	10.80
9.	BHAGCHEM	263.40	124.10	3415.48	0.06	133.29	3249.84	1950.19	1475.55	4.55	15.65
10.	GSPCROP	491.20	23.34	2285.00	0.20	263.94	1111.46	3859.95	1153.27	18.46	11.02
11.	BHARATRAS	1170.30	13.57	1945.16	0.04	372.30	838.73	3381.60	796.03	16.63	15.19
12.	ASTEC	762.70	0.00	1699.51	0.00	-18.71	43.36	83.56	-8.25	-5.71	-0.80

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	143	111	51	154	69	99	94	120	91	74	125	159	84
	140	114	69	141	116	118	100	114	102	80	121	149	103
Operating Profit	3	-3	-18	13	-46	-20	-6	6	-11	-7	4	9	-19
OPM %	2.20%	-3.09%	-36.09%	8.27%	-66.67%	-20.02%	-6.12%	4.63%	-12.07%	-9.06%	3.20%	5.77%	-23.32%
	2	1	1	2	1	2	2	1	0	1	-1	3	1
Interest	6	6	6	7	7	9	10	10	11	8	7	8	8
Depreciation	9	9	9	9	9	11	11	12	12	10	11	12	11
Profit before Tax	-11	-18	-32	-1	-62	-39	-25	-16	-33	-24	-16	-8	-19
Tax %	25.66%	23.75%	24.50%	-3.12%	35.56%	-0.00%	-60.44%	-2.61%	-0.00%	-0.00%	-0.00%	2.02%	0.22%
Net Profit	-8	-13	-24	-1	-40	-39	-40	-16	-33	-24	-16	-8	-19
	-4.19	-6.86	-12.42	-0.50	-20.26	-19.67	-20.60	-8.21	-16.86	-11.39	-7.06	-3.49	-8.41

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	313	371	431	522	555	677	628	458	381	448	441
	250	302	354	437	443	522	552	464	447	453	454
Operating Profit	62	69	76	85	111	154	76	-6	-66	-5	-13
OPM %	19.92%	18.54%	17.73%	16.32%	20.08%	22.77%	12.14%	-1.29%	-17.36%	-1.01%	-2.95%
	-8	12	11	12	8	10	13	6	6	3	3
Interest	12	11	12	13	5	9	21	25	37	35	31
Depreciation	14	15	19	23	26	34	34	36	44	45	45
Profit before Tax	29	56	56	61	89	121	35	-62	-141	-81	-67
Tax %	33.30%	37.19%	36.04%	22.53%	27.04%	25.80%	26.77%	24.06%	4.47%	0.20%	0.30%
Net Profit	19	35	36	47	65	90	26	-47	-135	-81	-67
EPS	9.77	17.88	18.23	24.25	33.02	45.83	13.02	-23.96	-68.74	-36.36	—
Dividend Payout %	15.33%	8.38%	8.22%	6.18%	4.54%	3.27%	11.52%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 7%
5 Years:: -4%
3 Years:: -11%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: 6%
5 Years:: -12%
3 Years:: -20%
1 Year:: -16%

RETURN ON EQUITY

10 Years:: 5%
5 Years:: -10%
3 Years:: -28%
Last Year:: -26%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20	20	20	20	20	20	20	20	20	22
	118	149	182	226	289	376	399	349	214	367
	126	124	176	99	187	241	298	484	545	360
Trade Payables	57	100	64	203	129	190	177	89	82	88
	13	20	20	24	53	99	86	33	26	104
Total Liabilities	334	413	461	572	678	925	979	974	886	941
	103	115	167	194	213	340	318	386	499	459
Capital Work in Progress	8	42	19	22	112	14	112	148	0	0
	66	78	93	121	106	187	295	196	160	138
	0	0	0	0	0	0	0	169	147	248
Cash & Bank	4	1	1	1	2	2	1	1	1	11
	153	176	181	233	245	383	251	73	78	85
Total Assets	334	413	461	572	678	925	979	974	886	941

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	26	80	32	187	15	53	79	10	-8	-81
Cash from Investing	-18	-49	-52	-74	-73	-104	-112	-135	-15	-4
Cash from Financing	-1	-18	37	-95	81	80	38	125	24	94
	1	-2	-0	0	0	0	-0	0	0	9

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	66.75	66.75	66.75	70.87	70.87	72.42	71.97	71.97	71.96
	1.03	0.53	1.20	0.25	0.02	0.00	0.04	0.03	0.01
	3.37	4.50	4.63	4.34	4.26	4.01	3.17	3.33	3.33
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	28.84	28.21	27.42	24.54	24.84	23.57	24.82	24.67	24.69

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10

Price movement

2026-09-10 - Significant movement in price has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

2026-09-09

Spurt in Volume

2026-09-09 - Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.

2026-09-08

Spurt in Volume

2026-09-08 - Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

2026-08-01

Copy of Newspaper Publication

2026-08-01 - Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-31

Updates

2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding 'Adoption of Annual Report 2025-26 by the Shareholders at the AGM held on 31st July, 2026.'.

2026-07-31

Shareholders meeting

2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 31, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

2026-07-31

General Updates

2026-07-31 - Astec LifeSciences Limited has informed the Exchange about General Updates

2026-07-31

Press Release

2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "ASTEC: Astec LifeSciences Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Press Release for the Quarter ended June 30, 2026".

2026-07-31

Outcome of Board Meeting

2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding Outcome of Board Meeting held on July 31, 2026.

News

Recent coverage and analyst commentary for ASTEC

Loading news…

🤖

AI Stock Analyst

Astec Lifesciences Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

UPL

577.00

24.11

48708.57

1.04

-73.00

58.52

10181.00

10.47

12.00

13.43

PIIND

2396.05

31.20

36352.42

0.63

244.20

-38.95

1702.30

-10.43

16.00

21.69

SUMICHEM

481.50

41.48

24033.87

0.27

214.51

20.45

1063.35

0.62

23.39

21.94

BAYERCROP

3948.35

320.25

17744.71

3.80

321.60

15.39

1835.00

-4.16

30.08

20.03

SHARDACROP

783.10

11.28

7065.17

1.92

88.02

-38.36

1073.77

9.03

31.10

17.32

DHANUKA

977.80

14.68

4358.87

0.20

75.50

27.94

442.02

20.01

24.44

24.83

RALLIS

203.90

24.15

3965.22

1.47

-14.15

-274.26

507.54

7.70

13.23

-0.56

NACLIND

164.35

311.22

3849.79

0.00

20.84

59.82

383.33

-14.50

6.20

10.80

BHAGCHEM

263.40

124.10

3415.48

0.06

133.29

3249.84

1950.19

1475.55

4.55

15.65

GSPCROP

491.20

23.34

2285.00

0.20

263.94

1111.46

3859.95

1153.27

18.46

11.02

BHARATRAS

1170.30

13.57

1945.16

0.04

372.30

838.73

3381.60

796.03

16.63

15.19

ASTEC

762.70

0.00

1699.51

0.00

-18.71

43.36

83.56

-8.25

-5.71

-0.80

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

143

111

154

120

125

159

140

114

141

116

118

100

114

102

121

149

103

Operating Profit

-3

-18

-46

-20

-6

-11

-7

-19

OPM %

2.20%

-3.09%

-36.09%

8.27%

-66.67%

-20.02%

-6.12%

4.63%

-12.07%

-9.06%

3.20%

5.77%

-23.32%

-1

Interest

Depreciation

Profit before Tax

-11

-18

-32

-1

-62

-39

-25

-16

-33

-24

-16

-8

-19

Tax %

25.66%

23.75%

24.50%

-3.12%

35.56%

-0.00%

-60.44%

-2.61%

-0.00%

2.02%

0.22%

Net Profit

-8

-13

-24

-1

-40

-39

-40

-16

-33

-24

-16

-8

-19

-4.19

-6.86

-12.42

-0.50

-20.26

-19.67

-20.60

-8.21

-16.86

-11.39

-7.06

-3.49

-8.41

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

313

371

431

522

555

677

628

458

381

448

441

250

302

354

437

443

522

552

464

447

453

454

Operating Profit

111

154

-6

-66

-5

-13

OPM %

19.92%

18.54%

17.73%

16.32%

20.08%

22.77%

12.14%

-1.29%

-17.36%

-1.01%

-2.95%

-8

Interest

Depreciation

Profit before Tax

121

-62

-141

-81

-67

Tax %

33.30%

37.19%

36.04%

22.53%

27.04%

25.80%

26.77%

24.06%

4.47%

0.20%

0.30%

Net Profit

-47

-135

-81

-67

EPS

9.77

17.88

18.23

24.25

33.02

45.83

13.02

-23.96

-68.74

-36.36

—

Dividend Payout %

15.33%

8.38%

8.22%

6.18%

4.54%

3.27%

11.52%

0.00%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

118

149

182

226

289

376

399

349

214

367

126

124

176

187

241

298

484

545

360

Trade Payables

100

203

129

190

177

104

Total Liabilities

334

413

461

572

678

925

979

974

886

941

103

115

167

194

213

340

318

386

499

459

Capital Work in Progress

112

148

121

106

187

295

196

160

138

169

147

248

Cash & Bank

153

176

181

233

245

383

251

Total Assets

334

413

461

572

678

925

979

974

886

941

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

187

-8

-81

Cash from Investing

-18

-49

-52

-74

-73

-104

-112

-135

-15

-4

Cash from Financing

-1

-18

-95

125

-2

-0

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

66.75

70.87

72.42

71.97

71.96

1.03

0.53

1.20

0.25

0.02

0.00

0.04

0.03

0.01

3.37

4.50

4.63

4.34

4.26

4.01

3.17

3.33

Government

0.00

28.84

28.21

27.42

24.54

24.84

23.57

24.82

24.67

24.69

Astec Lifesciences Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Astec Lifesciences Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI